Imported from EML workbook.
Formulations: - Parenteral > General injections > IM: 1.5 g per 5 mL in 5 mL ampoule Indications: - Visceral leishmaniasis - Mucocutaneous leishmaniasis - Cutaneous leishmaniasis Source: EML workbook import
Formulations: - Oral > Solid: 10 mg; 50 mg Indications: - Visceral leishmaniasis - Cutaneous leishmaniasis - Mucocutaneous leishmaniasis Source: EML workbook import
Formulations: - Parenteral > General injections > IM: 200 mg (as isetionate); 300 mg (as isetionate) - Oral > Solid > tablet: 200 mg (as isethionate); 300 mg (as isethionate) - Parenteral > General injections > IM: 300 mg in vial (as isetionate) powder for injection Indications: - Visceral leishmaniasis - Pneumocystosis - Gambiense trypanosomiasis Source: EML workbook import
Formulations: - Parenteral > General injections > unspecified: 100 mg per mL in 30 mL vial Indications: - Visceral leishmaniasis - Mucocutaneous leishmaniasis - Cutaneous leishmaniasis Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.
